Global survival studies have shown favorable development in most cancers but few studies have considered laryngeal cancer, particularly over extended periods or in populations for which medical care is essentially free of charge. We analyzed laryngeal and lung cancer incidence and survival in Finland (FI) and Sweden (SE) over a 50-year period (1970-2019) using data and statistical tools from the Nordcan database. Laryngeal cancer reached an incidence maximum in FI men in 1965, which in SE men occurred over 10 years later and peaking at 42% of the FI maximum. The FI incidence halved in 20 years while halving of the SE rate took almost twice as long. At maximum the male rate exceeded the female rate 20 times in FI and 10 times in SE. Incidence rates for lung cancer were approximately 10 times higher than those for laryngeal cancer, and they peaked 5 to 10 years after laryngeal cancer in both countries. The female lung cancer rates increased through the follow-up time but laryngeal cancer rates were relatively stable. Relative 1-year survival data for laryngeal cancer remained at around 85% through 50 years, and 5-year survival lagged constantly around 65%. For lung cancer 1-year survival improved and reached about 50% by 2019. Even 5-year survival improved reaching 20 to 30%, except for FI men. Incidence rates for laryngeal and lung cancers have drastically decreased in FI and SE men parallel to reduced smoking prevalence. In females, rates have clearly increased in lung but not in FI laryngeal cancer. This finding warrants further investigations into possible contributing factors, other than smoking. Survival in laryngeal cancer has not improved compared to the positive development in lung cancer. Historical smoking prevalence was unrelated of survival trends. As long-term survival in these cancers remains discouraging, the most efficient way to fight them is to target the main cause and promote non-smoking.

Biomedical Center Faculty of Medicine and Biomedical Center in Pilsen Charles University Prague Pilsen Czech Republic

Department of Otorhinolaryngology Head and Neck Surgery Helsinki University Hospital and University of Helsinki Helsinki Finland

Department of Urology Helsinki University Hospital and University of Helsinki Helsinki Finland

Division of Cancer Epidemiology German Cancer Research Center Heidelberg Germany

Division of Pediatric Neurooncology German Cancer Research Center Heidelberg Germany

Hopp Children's Cancer Center Heidelberg Germany

Zobrazit více v PubMed

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. Volume 100E. A review of human carcinogens. IARC Monogr. Eval. Carcinog. Risks Hum. 2012;100(PtE):1–538. ; PubMed Central PMCID: PMC4781577. PubMed PMC

Tindle HA, Stevenson Duncan M, Greevy RA, Vasan RS, Kundu S, Massion PP, et al.. Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study. J Natl Cancer Inst. 2018;110(11):1201–7. Epub 2018/05/23. doi: 10.1093/jnci/djy041 ; PubMed Central PMCID: PMC6235683. PubMed DOI PMC

Brown KF, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A, et al.. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118(8):1130–41. Epub 2018/03/24. doi: 10.1038/s41416-018-0029-6 ; PubMed Central PMCID: PMC5931106. PubMed DOI PMC

Hakulinen T, Engholm G, Gislum M, Storm HH, Klint A, Tryggvadóttir L, et al.. Trends in the survival of patients diagnosed with cancers in the respiratory system in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol. 2010;49(5):608–23. Epub 2010/02/23. doi: 10.3109/02841860903575281 . PubMed DOI

Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res. 2015;4(4):327–38. Epub 2015/09/18. doi: 10.3978/j.issn.2218-6751.2015.08.04 ; PubMed Central PMCID: PMC4549470. PubMed DOI PMC

GBD 2015 Tobacco Collaborators GBoDT. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–906. Epub 2017/04/10. doi: 10.1016/S0140-6736(17)30819-X ; PubMed Central PMCID: PMC5439023. PubMed DOI PMC

Hemminki K, Försti A, Hemminki A, Ljungberg B, Hemminki O. Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic. Eur J Cancer Prev. 2021. Epub 2021/06/03. doi: 10.1097/cej.0000000000000694 . PubMed DOI

Patja K, Hakala SM, Boström G, Nordgren P, Haglund M. Trends of tobacco use in Sweden and Finland: do differences in tobacco policy relate to tobacco use? Scand J Public Health. 2009;37(2):153–60. Epub 2009/01/24. doi: 10.1177/1403494808100277 . PubMed DOI

Mårdh O, Quinten C, Amato-Gauci AJ, Duffell E. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA—descriptive analysis and estimation of 2015 baseline. Infect Dis (Lond). 2020;52(9):625–37. Epub 2020/07/10. doi: 10.1080/23744235.2020.1766104 . PubMed DOI

Storm HH, Engholm G, Hakulinen T, Tryggvadóttir L, Klint A, Gislum M, et al.. Survival of patients diagnosed with cancer in the Nordic countries up to 1999–2003 followed to the end of 2006. A critical overview of the results. Acta Oncol. 2010;49(5):532–44. Epub 2010/05/25. doi: 10.3109/02841861003801148 . PubMed DOI

Ellis L, Woods LM, Estève J, Eloranta S, Coleman MP, Rachet B. Cancer incidence, survival and mortality: explaining the concepts. Int J Cancer. 2014;135(8):1774–82. Epub 2014/06/20. doi: 10.1002/ijc.28990 . PubMed DOI

Platek AJ, Jayaprakash V, Merzianu M, Platek ME, Cohan DM, Hicks WL Jr., et al.. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation. The Laryngoscope. 2016;126(12):2733–8. Epub 2016/06/28. doi: 10.1002/lary.26083 ; PubMed Central PMCID: PMC5880216. PubMed DOI PMC

Vawda N, Banerjee RN, Debenham BJ. Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery. Int J Radiat Oncol Biol Phys. 2019;103(5):1125–31. Epub 2018/12/05. doi: 10.1016/j.ijrobp.2018.11.046 . PubMed DOI

Park SY, Lee JG, Kim J, Bae MK, Lee CY, Kim DJ, et al.. The influence of smoking intensity on the clinicopathologic features and survival of patients with surgically treated non-small cell lung cancer. Lung Cancer. 2013;81(3):480–6. Epub 2013/07/31. doi: 10.1016/j.lungcan.2013.07.002 . PubMed DOI

Okamoto T, Suzuki Y, Fujishita T, Kitahara H, Shimamatsu S, Kohno M, et al.. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer—differences between adenocarcinoma and squamous cell carcinoma. Lung Cancer. 2014;85(2):125–30. Epub 2014/07/01. doi: 10.1016/j.lungcan.2014.06.006 . PubMed DOI

Nahavandipour A, Jakobsen KK, Grønhøj C, Hebbelstrup Jensen D, Kim Schmidt Karnov K, Klitmøller Agander T, et al.. Incidence and survival of laryngeal cancer in Denmark: a nation-wide study from 1980 to 2014. Acta Oncol. 2019;58(7):977–82. Epub 2019/03/02. doi: 10.1080/0284186X.2019.1572923 . PubMed DOI

Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nature reviews Disease primers. 2020;6(1):92. Epub 2020/11/28. doi: 10.1038/s41572-020-00224-3 ; PubMed Central PMCID: PMC7944998. PubMed DOI PMC

Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA Cancer J Clin. 2017;67(1):31–50. Epub 2016/11/30. doi: 10.3322/caac.21386 . PubMed DOI

Maconachie R, Mercer T, Navani N, McVeigh G. Lung cancer: diagnosis and management: summary of updated NICE guidance. Bmj. 2019;364:l1049. Epub 2019/03/30. doi: 10.1136/bmj.l1049 . PubMed DOI

Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al.. NORDCAN—a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725–36. Epub 2010/05/25. doi: 10.3109/02841861003782017 . PubMed DOI

Pukkala E, Engholm G, Hojsgaard Schmidt LK, Storm H, Khan S, Lambe M, et al.. Nordic Cancer Registries—an overview of their procedures and data comparability. Acta Oncol. 2018;57:440–55. Epub 2017/12/12. doi: 10.1080/0284186X.2017.1407039 . PubMed DOI

Ji J, Sundquist K, Sundquist J, Hemminki K. Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry. Int J Cancer. 2012;131:2085–93. Epub 2012/02/07. doi: 10.1002/ijc.27462 . PubMed DOI

Centre for Epidemiology. Cancer incidence in Sweden 2012. Stockholm: The National Board of Health and Welfare; 2013.

Storm HH, Klint A, Tryggvadóttir L, Gislum M, Engholm G, Bray F, et al.. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol. 2010;49(5):694–712. Epub 2010/05/25. doi: 10.3109/02841861003631495 . PubMed DOI

Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncol. 2010;49(5):545–60. Epub 2010/05/25. doi: 10.3109/02841861003739322 . PubMed DOI

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco Smoke and Involuntary Smoking. IARC Monogr. Eval. Carcinog. Risks hum. 2004;83:1–1438. ; PMCID: PMC4781536. PubMed PMC

Tenkanen L, Hakulinen T, Hakama M, Saxén E. Sauna, dust and migration as risk factors in lung cancer among smoking and non-smoking males in Finland. Int J Cancer. 1985;35(5):637–42. Epub 1985/05/15. doi: 10.1002/ijc.2910350511 . PubMed DOI

Hemminki K, Försti A, Hemminki A, Ljungberg B, Hemminki O. Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden. PLoS One. 2021;16(6):e0253236. Epub 2021/06/23. doi: 10.1371/journal.pone.0253236 ; PubMed Central PMCID: PMC8219161 PubMed DOI PMC

Shin JY, Yoon JK, Marwaha G. Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer. Lung. 2018;196(3):351–8. Epub 2018/03/20. doi: 10.1007/s00408-018-0110-1 . PubMed DOI

Thun M, Peto R, Boreham J, Lopez AD. Stages of the cigarette epidemic on entering its second century. Tob Control. 2012;21(2):96–101. Epub 2012/02/22. doi: 10.1136/tobaccocontrol-2011-050294 . PubMed DOI

Lipfert FW, Wyzga RE. Longitudinal relationships between lung cancer mortality rates, smoking, and ambient air quality: a comprehensive review and analysis. Crit Rev Toxicol. 2019;49(9):790–818. Epub 2020/01/28. doi: 10.1080/10408444.2019.1700210 . PubMed DOI

Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century

Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century